Recent changes in the regulations from the FDA and EMA have shifted the focus of juvenile toxicity studies more to the safe use of all pharmaceuticals and the absence of label or safety information for the pediatric population.
The Value of Juvenile Animal Studies “What Have We Learned From Preclinical Juvenile Toxicity Studies? II”
Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2011